Ever wonder why some portfolios keep delivering steady income even when the market turns choppy? Dividend growth stocks have a quiet edge. According to Hartford Funds’ analysis with Ned Davis Research, S&P 500 stocks…
The market has spent much of 2026 stuck between two competing forces — stubbornly high interest rates and a growing expectation they’ll eventually fall. That tension has left income investors asking a simple question:…
Somehow, members of Congress have turned relatively modest salaries into impressive investment portfolios while the rest of us grind it out in the market. For years, questions have swirled around lawmakers buying and selling…
The market has spent much of the year rewarding caution and punishing complacency. After a long stretch where mega-cap tech felt untouchable, volatility has crept back in — driven by shifting interest-rate expectations, AI…
The market has a funny way of chasing what’s visible while missing what actually powers it. Everyone is focused on AI chips, software, and trillion-dollar tech giants. But here’s the question investors should be…
QuantumScape (NYSE:QS | QS Price Prediction), the pre-revenue solid-state battery developer, used its Q4 2025 report to pair a narrow earnings beat with a strategic pivot: chasing AI data centers, robotics, aviation and defense…
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule III. But…
The stock market loves a clean story — growth company, value play, or cyclical rebound. Tesla (NASDAQ:TSLA | TSLA Price Prediction) used to fit neatly into the first category: the high-octane EV disruptor rewriting…
Texas Instruments (NASDAQ:TXN | TXN Price Prediction) just delivered the kind of quarter that validates the entire data center infrastructure thesis. The analog chipmaker posted Q1 FY2026 revenue of $4.83 billion, beating the $4.53…
IBM (NYSE:IBM | IBM Price Prediction) delivered a clean beat on both lines for Q1 2026, yet shares are getting punished anyway. The stock opened sharply lower Thursday, trading at $228 after closing at…
ServiceNow (NYSE:NOW | NOW Price Prediction) delivered a textbook beat-and-raise quarter for Q1, yet the tape told a different story. Shares are falling than 13% in morning trading to $88.70 after the workflow giant…
The AI arms race isn’t just about who builds the smartest chatbot — it’s about who supplies the plumbing. When Anthropic expanded its partnership with Amazon (NASDAQ:AMZN | AMZN Price Prediction) to a reported…
The idea of a $1.5 trillion U.S. defense budget sounds abstract until you translate it into procurement lines, contract awards, and long-cycle government spending that quietly reshapes entire industries. That’s where things get interesting…
Las Vegas Sands (NYSE:LVS | LVS Price Prediction) reports Q1 2026 results today after the close, with a conference call at 1:30 p.m. PT. The stock is up 8.71% over the past month but…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) delivered its most convincing quarter in over a year on April 21, 2026, posting a 9.38% EPS beat and raising full-year guidance, sending shares up 6.96% on…
AI spending in 2026 is starting to look less like a budget line item and more like a strategic arms race. Companies are no longer asking whether to adopt AI, but who owns the…
Texas Instruments (NASDAQ:TXN | TXN Price Prediction) reports Q1 2026 results today after the market closes. With data center revenue accelerating and a massive manufacturing buildout nearing completion, the question is whether the AI…
Molina Healthcare (NYSE:MOH | MOH Price Prediction) reports first-quarter 2026 results after the market closes today. After a brutal year that sent shares down 50.01% over the past 12 months, the question is whether…
American Express (NYSE:AXP | AXP Price Prediction) reports first-quarter 2026 results after the market closes tomorrow, April 23. With a fresh acquisition, a deepening AI strategy, and a macro backdrop that management itself flagged…
The GLP-1 weight-loss category exploded into a multi-billion-dollar opportunity that blends medication access with ongoing patient support. This morning, Amazon‘s (NASDAQ:AMZN | AMZN Price Prediction) One Medical platform rolled out a national program that…
